Sandoz Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
1106 result(s) found, displaying 51 to 60
-
Australian Public Assessment Report (AusPAR)Jubbonti (a biosimilar to Prolia), and Wyost (a biosimilar to XGEVA), were approved to improve bone density and to reduce bone fracture risk as a consequence of disease or medications that weaken bones.
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DUTASTERIDE/TAMSULOSIN SANDOZ 500/400 dutasteride 500 microgram and tamsulosin hydrochloride 400 microgram modified release capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DUTASTERIDE/TAMSULOSIN SANDOZ 500/400 dutasteride 500 microgram and tamsulosin hydrochloride 400 microgram modified release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYRIMOZ adalimumab 40 mg/0.4 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYRIMOZ adalimumab 20 mg/0.2 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYRIMOZ adalimumab 80 mg/0.8 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYRIMOZ adalimumab 80 mg/0.8 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYRIMOZ adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe.
-